AN experimental blood test that detected Parkinson’s disease in a preliminary study could become the first specific tool for diagnosing the devastating neurodegenerative condition, researchers said.
The test, which looks for cell damage associated with the disease, is years away from being commercially available. If its reliability is confirmed in future trials, the test would allow doctors to diagnose the condition earlier and start therapies sooner, before nervous system damage worsens, the researchers said.
“Currently, Parkinson’s disease is diagnosed largely based on symptoms, when patients already have significant neurological damage,” said study leader Laurie Sanders of Duke School of Medicine in Durham, North Carolina.
The new blood test measures DNA damage in mitochondria, the structures inside cells that generate energy for cellular functions. Mitochondrial DNA damage is known to be associated with Parkinson's disease.
The test showed greater damage in blood cells from patients with Parkinson’s compared to people without the disease, researchers reported in Science Translational Medicine.
It also found elevated DNA damage in people with a genetic mutation called LRRK2 that increases the risk for Parkinson’s disease, even in the absence of symptoms, they said.
Presently, drugs for Parkinson’s disease only help control symptoms. Sanders said she hopes that along with diagnosing Parkinson’s, the new test will help identify drugs that can reverse or halt mitochondrial DNA damage and the disease process, as well as patients who could benefit from those drugs.
Several companies including Abcam and Biogen with partner Denali Therapeutics are testing such experimental treatments.
"A new blood-based diagnostic test would be a major advancement for Parkinson’s disease, which afflicts 10 million people worldwide and is the second most common neurodegenerative disease after Alzheimer's," the researchers said.
Going forward, the researchers plan to test the diagnostic in samples from high-risk individuals who have not yet developed symptoms.
Reuters
Fri Sep 01 2023
The new blood test measures DNA damage in mitochondria, the structures inside cells that generate energy for cellular functions. - UNSPLASH
Kesuma percepat penubuhan Suruhanjaya Pekerja Gig, laporan interim Jun ini
Steven Sim berkata kajian sedang dilakukan dengan kerjasama Universiti Malaya (UM) sebelum laporan interim dijangka dibentangkan kepada Kabinet menjelang 1 Jun ini.
Malaysia tutup kempen Piala Uber dengan kemenangan 4-1 ke atas Australia
Malaysia mendahului dalam perlawanan pembukaan menerusi pemain perseorangan wanita profesional negara Goh Jin Wei yang menewaskan Tiffany Ho, 21-6, 21-12.
Impak gaji penjawat awam naik lebih 13 peratus
Ketua Ekonomi Buruh di Kementerian Sumber Manusia dan Emiratisasi, Emiriah Arab Bersatu (UAE), Dr Yusof Saari berkata kenaikan gaji penjawat awam bakal memberi impak positif kepada pemulihan ekonomi. #AWANInews
3 terbunuh serangan peluru berpandu Rusia
Serangan turut mengakibatkan kerosakan infrastruktur awam.
Rumah kosong di Jepun pecah rekod, 9 juta unit
Jumlah rumah kosong di Jepun meningkat kepada rekod baharu 9 juta setakat Oktober 2023, iaitu kenaikan sebanyak 510,000 daripada tinjauan sebelumnya yang dijalankan pada 2018.
Kenaikan gaji penjawat awam akan diperincikan semasa pembentangan Belanjawan 2025 - Fahmi
Fahmi Fadzil berkata kenaikan gaji melebihi 13 peratus itu membuktikan komitmen kerajaan kepada penjawat awam.
Australia peruntukan AUD1 bilion banteras keganasan domestik, seksual
Perdana Menteri Australian umumkan peruntukan AUD1 bilion tangani jenayah kegasanan domestik dan seksual yang disifatkan sebagai krisis nasional negara itu.
Puluhan kakitangan berhimpun di Universiti Stanford
Universiti Standford, California antara puluhan institusi yang menyertai protes menggesa menghentikan pembunuhan beramai-ramai terhadap Gaza akibat serangan Israel.
Polis masuk Universiti Columbia, tahan beberapa individu
Pada Selasa, pelajar Universiti Colombia berikrar meneruskan siri protes di kampus sebagai solidariti menyokong Palestin, sekali gus melawan usaha pihak universiti untuk menghentikan mereka.
Tempat kediaman tertinggi dunia akan dibina di Dubai
Ia akan memintas menara Central Park Tower di New York yang berketinggian 472 meter.
CES 2019: IBM lancar prototaip 'sensor kuku' bantu pesakit kencing manis
IBM Research memperkenalkan prototaip 'sensor kuku' pertama, yang boleh mengubah cara menggunakan data klinikal, dengan menggabungkan pembelajaran kecerdasan buatan (AI) dan mesin.